# The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma

> **NCT05331313** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 1000 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **GENETIC:** DNA sequencing

## Key facts

- **NCT ID:** NCT05331313
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-08-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05331313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05331313, "The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05331313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*